Announcements Trials
Browse Landscape

Phase

Phase NA 11Phase 2 11Phase 4 3Phase 1/2 2Phase 3 1Phase 2/3 1

Status

Unknown 2

Sponsor Class

OTHER 180INDUSTRY 124NIH 63NETWORK 8OTHER_GOV 2INDIV 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 16Breast 14Thoracic 11Lymphoid 11Other hematologic neoplasm 8Plasma cell 4Gynecologic 4Genitourinary 4Head & Neck 3CNS 3Sarcoma 2Other solid neoplasm 2Myeloid 2Dermatologic 2Classical hematology 2Tumor-Agnostic 1

Conditions

Osteosarcoma 1Gliosarcoma 1Glioblastoma 1

Interventions

pembrolizumab 1ipatasertib 1dactolisib 1Ashwagandha 12-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × OTHER_GOV × Sarcoma × Clear all
NCT02430363 2016-02-24

Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475

Medical Research Council

Phase 1/2 Unknown
58 enrolled
CNSSarcoma

Glioblastoma, Gliosarcoma

NCT00689195 2011-06-23

OSCAT

Tata Memorial Hospital

Phase 1/2 Unknown
24 enrolled
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡